New nerve block cocktail aims to ease shoulder surgery pain
NCT ID NCT07626346
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding dexmedetomidine to the numbing drug bupivacaine in a nerve block can improve pain control after shoulder surgery. About 84 adults having laparoscopic shoulder surgery will be randomly assigned to receive either the drug combo or bupivacaine alone. The main goal is to see how long pain relief lasts and whether it reduces the need for additional painkillers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexmedetomidine added to bupivacaine
What this could lead to
If it works, this could provide longer-lasting pain relief after shoulder surgery and reduce the need for opioids.
What could go wrong
This is a small, early-stage trial with only 84 participants. The added drug may not improve pain control and could cause side effects like low blood pressure or slow heart rate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHOULDER PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kasr Alainy
RECRUITINGCairo, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••